Thermofluor-based high-throughput stability optimization of proteins for structural studies.

PubWeight™: 5.05‹?› | Rank: Top 1%

🔗 View Article (PMID 16962548)

Published in Anal Biochem on August 10, 2006

Authors

Ulrika B Ericsson1, B Martin Hallberg, George T Detitta, Niek Dekker, Pär Nordlund

Author Affiliations

1: Department of Biochemistry and Biophysics, Stockholm University, Stockholm SE-109 51, Sweden.

Articles citing this

(truncated to the top 100)

The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature (2009) 5.06

Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res (2008) 2.63

The Seattle Structural Genomics Center for Infectious Disease (SSGCID). Infect Disord Drug Targets (2009) 1.90

The Enzyme Function Initiative. Biochemistry (2011) 1.87

High-throughput thermal scanning: a general, rapid dye-binding thermal shift screen for protein engineering. J Am Chem Soc (2009) 1.85

Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog (2010) 1.73

A conserved spider silk domain acts as a molecular switch that controls fibre assembly. Nature (2010) 1.65

Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci U S A (2010) 1.64

DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Nat Struct Mol Biol (2011) 1.59

A primer to single-particle cryo-electron microscopy. Cell (2015) 1.56

A quantitative model of thermal stabilization and destabilization of proteins by ligands. Biophys J (2008) 1.40

The significance of G protein-coupled receptor crystallography for drug discovery. Pharmacol Rev (2011) 1.39

Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina. PLoS One (2010) 1.35

Structural analysis of specific metal chelating inhibitor binding to the endonuclease domain of influenza pH1N1 (2009) polymerase. PLoS Pathog (2012) 1.34

The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol (2009) 1.32

The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc (2014) 1.31

Nanoliter multiplex PCR arrays on a SlipChip. Anal Chem (2010) 1.30

Functional and structural studies of the nucleotide excision repair helicase XPD suggest a polarity for DNA translocation. EMBO J (2011) 1.28

Structure of the bacteriophage T4 long tail fiber receptor-binding tip. Proc Natl Acad Sci U S A (2010) 1.27

Buffer optimization of thermal melt assays of Plasmodium proteins for detection of small-molecule ligands. J Biomol Screen (2009) 1.25

Energetic dissection of Gleevec's selectivity toward human tyrosine kinases. Nat Struct Mol Biol (2014) 1.24

Calcium modulates force sensing by the von Willebrand factor A2 domain. Nat Commun (2011) 1.22

Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit. J Virol (2010) 1.19

Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation. J Biol Chem (2009) 1.17

LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment. Biophys J (2010) 1.13

The role of medical structural genomics in discovering new drugs for infectious diseases. PLoS Comput Biol (2009) 1.11

A fully synthetic human Fab antibody library based on fixed VH/VL framework pairings with favorable biophysical properties. MAbs (2013) 1.11

A plate-based high-throughput assay for virus stability and vaccine formulation. J Virol Methods (2012) 1.09

Autoacetylation of the histone acetyltransferase Rtt109. J Biol Chem (2011) 1.08

SUMO modification of the neuroprotective protein TDP1 facilitates chromosomal single-strand break repair. Nat Commun (2012) 1.08

Allosteric mechanism of pyruvate kinase from Leishmania mexicana uses a rock and lock model. J Biol Chem (2010) 1.06

Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol (2010) 1.04

Streptococcus pneumoniae choline-binding protein E interaction with plasminogen/plasmin stimulates migration across the extracellular matrix. Infect Immun (2007) 1.04

Angiopoietin-like protein 4 inhibition of lipoprotein lipase: evidence for reversible complex formation. J Biol Chem (2013) 1.03

The quorum-quenching N-acyl homoserine lactone acylase PvdQ is an Ntn-hydrolase with an unusual substrate-binding pocket. Proc Natl Acad Sci U S A (2009) 1.02

Functional identification of incorrectly annotated prolidases from the amidohydrolase superfamily of enzymes. Biochemistry (2009) 0.99

Crystallization screening: the influence of history on current practice. Acta Crystallogr F Struct Biol Commun (2014) 0.98

Protein stability by number: high-throughput and statistical approaches to one of protein science's most difficult problems. Curr Opin Chem Biol (2011) 0.98

Computational design of a self-assembling symmetrical β-propeller protein. Proc Natl Acad Sci U S A (2014) 0.98

Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.98

The AEROPATH project targeting Pseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discovery. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.97

Molecular basis for nucleotide conservation at the ends of the dengue virus genome. PLoS Pathog (2012) 0.97

Crystal structures of two transcriptional regulators from Bacillus cereus define the conserved structural features of a PadR subfamily. PLoS One (2012) 0.96

Serotype-specific structural differences in the protease-cofactor complexes of the dengue virus family. J Virol (2009) 0.94

Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J (2015) 0.94

A three-stage biophysical screening cascade for fragment-based drug discovery. Nat Protoc (2013) 0.94

Capsid structure and its stability at the late stages of bacteriophage SPP1 assembly. J Virol (2012) 0.94

Crystallization and preliminary X-ray analysis of CrgA, a LysR-type transcriptional regulator from pathogenic Neisseria meningitidis MC58. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.92

Crystal structure of GAP50, the anchor of the invasion machinery in the inner membrane complex of Plasmodium falciparum. J Struct Biol (2012) 0.92

Computationally designed libraries for rapid enzyme stabilization. Protein Eng Des Sel (2014) 0.92

Small-molecule inhibitor of the Shigella flexneri master virulence regulator VirF. Infect Immun (2013) 0.91

Intermolecular domain swapping induces intein-mediated protein alternative splicing. Nat Chem Biol (2013) 0.91

Effect of pH and temperature on the global compactness, structure, and activity of cellobiohydrolase Cel7A from Trichoderma harzianum. Eur Biophys J (2011) 0.90

SCMCRYS: predicting protein crystallization using an ensemble scoring card method with estimating propensity scores of P-collocated amino acid pairs. PLoS One (2013) 0.90

Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS One (2011) 0.90

Biochemical and mutational analysis of a novel nicotinamidase from Oceanobacillus iheyensis HTE831. PLoS One (2013) 0.89

Optimization of protein buffer cocktails using Thermofluor. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.88

Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. PLoS One (2013) 0.88

7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland. MAbs (2012) 0.88

Biophysical characterization of recombinant proteins: a key to higher structural genomics success. J Struct Biol (2010) 0.88

The nuclease domain of the SPP1 packaging motor coordinates DNA cleavage and encapsidation. Nucleic Acids Res (2012) 0.88

CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil. Nat Commun (2016) 0.88

Participation of protein sequence termini in crystal contacts. Protein Sci (2011) 0.87

Binding of Cyclic Di-AMP to the Staphylococcus aureus Sensor Kinase KdpD Occurs via the Universal Stress Protein Domain and Downregulates the Expression of the Kdp Potassium Transporter. J Bacteriol (2015) 0.87

Assembly mechanism of Trypanosoma brucei BILBO1, a multidomain cytoskeletal protein. J Biol Chem (2014) 0.87

Co2+ selectivity of Thermotoga maritima CorA and its inability to regulate Mg2+ homeostasis present a new class of CorA proteins. J Biol Chem (2011) 0.87

Measurement of nanomolar dissociation constants by titration calorimetry and thermal shift assay - radicicol binding to Hsp90 and ethoxzolamide binding to CAII. Int J Mol Sci (2009) 0.87

Structure of the effector-binding domain of the arabinose repressor AraR from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr (2012) 0.86

Analysis of protein stability and ligand interactions by thermal shift assay. Curr Protoc Protein Sci (2015) 0.86

Molecular characterization of a novel N-acetylneuraminate lyase from Lactobacillus plantarum WCFS1. Appl Environ Microbiol (2011) 0.86

Optimization of crystallization conditions for biological macromolecules. Acta Crystallogr F Struct Biol Commun (2014) 0.86

Structure of allergens and structure based epitope predictions. Methods (2013) 0.86

On the relevance of the Met-turn methionine in metzincins. J Biol Chem (2010) 0.86

The Q motif of Fanconi anemia group J protein (FANCJ) DNA helicase regulates its dimerization, DNA binding, and DNA repair function. J Biol Chem (2012) 0.86

Crystal structure of the variable domain of the Streptococcus gordonii surface protein SspB. Protein Sci (2009) 0.86

Bipartite Topology of Treponema pallidum Repeat Proteins C/D and I: OUTER MEMBRANE INSERTION, TRIMERIZATION, AND PORIN FUNCTION REQUIRE A C-TERMINAL β-BARREL DOMAIN. J Biol Chem (2015) 0.85

Deep transcriptome-sequencing and proteome analysis of the hydrothermal vent annelid Alvinella pompejana identifies the CvP-bias as a robust measure of eukaryotic thermostability. Biol Direct (2013) 0.85

Identification of inhibitors that block vaccinia virus infection by targeting the DNA synthesis processivity factor D4. J Med Chem (2011) 0.85

Mutagenesis of zinc ligand residue Cys221 reveals plasticity in the IMP-1 metallo-β-lactamase active site. Antimicrob Agents Chemother (2012) 0.85

Expression, purification, and initial characterization of different domains of recombinant mouse 2',3'-cyclic nucleotide 3'-phosphodiesterase, an enigmatic enzyme from the myelin sheath. BMC Res Notes (2010) 0.85

Use of differential scanning fluorimetry to optimize the purification and crystallization of PLP-dependent enzymes. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.84

Conformational dynamics of the Escherichia coli DNA polymerase manager proteins UmuD and UmuD'. J Mol Biol (2010) 0.84

UDP-glucose dehydrogenase polymorphisms from patients with congenital heart valve defects disrupt enzyme stability and quaternary assembly. J Biol Chem (2012) 0.84

Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia. Biochim Biophys Acta (2013) 0.84

The BAH domain of Rsc2 is a histone H3 binding domain. Nucleic Acids Res (2013) 0.84

Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants. PLoS One (2015) 0.83

Crystallization and preliminary X-ray crystallographic analysis of tyrosinase from the mushroom Agaricus bisporus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.83

The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Nucleic Acids Res (2013) 0.83

Allosteric mutants show that PrfA activation is dispensable for vacuole escape but required for efficient spread and Listeria survival in vivo. Mol Microbiol (2012) 0.83

Neisseria meningitidis expresses a single 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase that is inhibited primarily by phenylalanine. Protein Sci (2013) 0.82

Assessing the Efficacy of Mdm2/Mdm4-Inhibiting Stapled Peptides Using Cellular Thermal Shift Assays. Sci Rep (2015) 0.82

Thermus thermophilus glycoside hydrolase family 57 branching enzyme: crystal structure, mechanism of action, and products formed. J Biol Chem (2010) 0.82

Differential scanning fluorometry signatures as indicators of enzyme inhibitor mode of action: case study of glutathione S-transferase. PLoS One (2012) 0.82

Ligand binding analysis and screening by chemical denaturation shift. Anal Biochem (2013) 0.82

The dimeric SOS mutagenesis protein UmuD is active as a monomer. J Biol Chem (2010) 0.82

The molecular dynamics of Trypanosoma brucei UDP-galactose 4'-epimerase: a drug target for African sleeping sickness. Chem Biol Drug Des (2012) 0.82

Prediction of protein crystallization outcome using a hybrid method. J Struct Biol (2010) 0.82

Structural and functional analyses reveal that Staphylococcus aureus antibiotic resistance factor HmrA is a zinc-dependent endopeptidase. J Biol Chem (2011) 0.82

The hexameric structure of the human mitochondrial replicative helicase Twinkle. Nucleic Acids Res (2015) 0.82

Determination of protein-ligand interactions using differential scanning fluorimetry. J Vis Exp (2014) 0.81

Articles by these authors

Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination. Proc Natl Acad Sci U S A (2006) 4.45

Protein production and purification. Nat Methods (2008) 3.97

In situ proteolysis for protein crystallization and structure determination. Nat Methods (2007) 3.05

Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science (2013) 2.74

Crystal structure of a divalent metal ion transporter CorA at 2.9 angstrom resolution. Science (2006) 2.23

Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol (2011) 2.23

Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature (2007) 2.17

The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif (2007) 2.10

The crystal structure of the human toll-like receptor 10 cytoplasmic domain reveals a putative signaling dimer. J Biol Chem (2008) 1.89

MTERF4 regulates translation by targeting the methyltransferase NSUN4 to the mammalian mitochondrial ribosome. Cell Metab (2011) 1.68

The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass. Science (2004) 1.53

An efficient strategy for high-throughput expression screening of recombinant integral membrane proteins. Protein Sci (2005) 1.48

Structural basis for recognition by an in vitro evolved affibody. Proc Natl Acad Sci U S A (2003) 1.46

Displacement of the tyrosyl radical cofactor in ribonucleotide reductase obtained by single-crystal high-field EPR and 1.4-A x-ray data. Proc Natl Acad Sci U S A (2003) 1.38

Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase. Nat Struct Mol Biol (2004) 1.32

Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters. Nat Struct Mol Biol (2013) 1.31

Lessons from high-throughput protein crystallization screening: 10 years of practical experience. Expert Opin Drug Discov (2011) 1.29

Enabling IMAC purification of low abundance recombinant proteins from E. coli lysates. Nat Methods (2009) 1.23

Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studies. Mol Microbiol (2008) 1.22

Crystal structure of a human mitochondrial deoxyribonucleotidase. Nat Struct Biol (2002) 1.22

Efficient optimization of crystallization conditions by manipulation of drop volume ratio and temperature. Protein Sci (2007) 1.22

Molecular and structural basis for redox regulation of beta-actin. J Mol Biol (2007) 1.20

Establishing a training set through the visual analysis of crystallization trials. Part I: approximately 150,000 images. Acta Crystallogr D Biol Crystallogr (2008) 1.15

Completing the family portrait of the anti-apoptotic Bcl-2 proteins: crystal structure of human Bfl-1 in complex with Bim. FEBS Lett (2008) 1.13

Lipopolysaccharide regions involved in the activation of Escherichia coli outer membrane protease OmpT. Eur J Biochem (2002) 1.11

Structural basis for substrate binding and regioselective oxidation of monosaccharides at C3 by pyranose 2-oxidase. J Biol Chem (2006) 1.11

Structural and biophysical characterization of the cytoplasmic domains of human BAP29 and BAP31. PLoS One (2013) 1.09

Crystal structure of the di-iron/radical protein of ribonucleotide reductase from Corynebacterium ammoniagenes. Biochemistry (2002) 1.08

Structural insights into substrate recognition in proton-dependent oligopeptide transporters. EMBO Rep (2013) 1.08

TRPV1: a therapy target that attracts the pharmaceutical interests. Adv Exp Med Biol (2011) 1.05

Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli. Nat Methods (2005) 1.04

Engineering membrane protein overproduction in Escherichia coli. Protein Sci (2008) 1.03

Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J (2009) 1.02

Determination and application of empirically derived detergent phase boundaries to effectively crystallize membrane proteins. Protein Sci (2009) 1.02

Structure of Rhodococcus erythropolis limonene-1,2-epoxide hydrolase reveals a novel active site. EMBO J (2003) 1.02

The closed structure of presequence protease PreP forms a unique 10,000 Angstroms3 chamber for proteolysis. EMBO J (2006) 1.02

Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition. J Biol Chem (2007) 1.02

The structure of the RNA m5C methyltransferase YebU from Escherichia coli reveals a C-terminal RNA-recruiting PUA domain. J Mol Biol (2006) 1.00

The structure of human collapsin response mediator protein 2, a regulator of axonal growth. J Neurochem (2007) 0.99

Structure of the human MTERF4-NSUN4 protein complex that regulates mitochondrial ribosome biogenesis. Proc Natl Acad Sci U S A (2012) 0.96

Catalysis within the lipid bilayer-structure and mechanism of the MAPEG family of integral membrane proteins. Curr Opin Struct Biol (2008) 0.96

An efficient and generic strategy for producing soluble human proteins and domains in E. coli by screening construct libraries. Proteins (2006) 0.95

RNA-protein mutually induced fit: structure of Escherichia coli isopentenyl-tRNA transferase in complex with tRNA(Phe). J Biol Chem (2009) 0.94

Efficiency of hit generation and structural characterization in fragment-based ligand discovery. Curr Opin Chem Biol (2011) 0.94

A high throughput method for the detection of metalloproteins on a microgram scale. Mol Cell Proteomics (2005) 0.94

Catalytic mechanism of limonene epoxide hydrolase, a theoretical study. J Am Chem Soc (2005) 0.93

Structure of the synthetase domain of human CTP synthetase, a target for anticancer therapy. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.91

High-throughput analytical gel filtration screening of integral membrane proteins for structural studies. Biochim Biophys Acta (2013) 0.91

Arginine 104 is a key catalytic residue in leukotriene C4 synthase. J Biol Chem (2010) 0.91

Crystal structure of CaiB, a type-III CoA transferase in carnitine metabolism. Biochemistry (2004) 0.91

Crystal structure of YegS, a homologue to the mammalian diacylglycerol kinases, reveals a novel regulatory metal binding site. J Biol Chem (2007) 0.91

The crystal structure of a human PP2A phosphatase activator reveals a novel fold and highly conserved cleft implicated in protein-protein interactions. J Biol Chem (2006) 0.90

A prokaryotic alternative oxidase present in the bacterium Novosphingobium aromaticivorans. FEBS Lett (2003) 0.89

TFAM forces mtDNA to make a U-turn. Nat Struct Mol Biol (2011) 0.89

X-ray structure of tRNA pseudouridine synthase TruD reveals an inserted domain with a novel fold. FEBS Lett (2004) 0.89

Structural basis for the allosteric regulation and substrate recognition of human cytosolic 5'-nucleotidase II. J Mol Biol (2011) 0.89

EPR studies of the mitochondrial alternative oxidase. Evidence for a diiron carboxylate center. J Biol Chem (2002) 0.89

Structural studies of tri-functional human GART. Nucleic Acids Res (2010) 0.88

A simple strategy towards membrane protein purification and crystallization. Int J Biol Macromol (2006) 0.88

Structural and biophysical characterization of human myo-inositol oxygenase. J Biol Chem (2008) 0.88

The crystal structure of human cleavage and polyadenylation specific factor-5 reveals a dimeric Nudix protein with a conserved catalytic site. Proteins (2008) 0.87

Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T. J Biol Chem (2006) 0.87

The crystal structure of the protein YhaK from Escherichia coli reveals a new subclass of redox sensitive enterobacterial bicupins. Proteins (2009) 0.87

Fragment-based ligand design of novel potent inhibitors of tankyrases. J Med Chem (2013) 0.87

The structure of the PP2A regulatory subunit B56 gamma: the remaining piece of the PP2A jigsaw puzzle. Proteins (2009) 0.86

First structure of a eukaryotic phosphohistidine phosphatase. J Biol Chem (2006) 0.86

Crystal structures of human and murine deoxyribonucleotidases: insights into recognition of substrates and nucleotide analogues. Biochemistry (2007) 0.85

Structural basis for substrate specificity of the human mitochondrial deoxyribonucleotidase. Structure (2005) 0.85

The crystal structure of the bifunctional deaminase/reductase RibD of the riboflavin biosynthetic pathway in Escherichia coli: implications for the reductive mechanism. J Mol Biol (2006) 0.84

Biophysical and structural analysis of a novel heme B iron ligation in the flavocytochrome cellobiose dehydrogenase. J Biol Chem (2003) 0.84

Structural basis for adenosylcobalamin activation in AdoCbl-dependent ribonucleotide reductases. ACS Chem Biol (2010) 0.84

Optimisation of over-expression in E. coli and biophysical characterisation of human membrane protein synaptogyrin 1. PLoS One (2012) 0.83

Reaction mechanism of deoxyribonucleotidase: a theoretical study. J Phys Chem B (2005) 0.83

The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Nucleic Acids Res (2013) 0.83

Structural and mutational studies of the carboxylate cluster in iron-free ribonucleotide reductase R2. Biochemistry (2004) 0.83

Cofactor mobility determines reaction outcome in the IMPDH and GMPR (β-α)8 barrel enzymes. Nat Chem Biol (2011) 0.83

Metal-mediated crystallization of the xylose transporter XylE from Escherichia coli in three different crystal forms. J Struct Biol (2013) 0.83

The use of TrkA-PathHunter assay in high-throughput screening to identify compounds that affect nerve growth factor signaling. J Biomol Screen (2013) 0.82

The heme domain of cellobiose oxidoreductase: a one-electron reducing system. Biochim Biophys Acta (2003) 0.82

A synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discovery. ACS Chem Biol (2012) 0.81

Understanding specificity in metabolic pathways--structural biology of human nucleotide metabolism. Biochem Biophys Res Commun (2010) 0.81

High-resolution insights into binding of unfolded polypeptides by the PPIase chaperone SlpA. FASEB J (2012) 0.81

TRPV1 signaling: mechanistic understanding and therapeutic potential. Curr Top Med Chem (2011) 0.81

The crystal structure of the Dachshund domain of human SnoN reveals flexibility in the putative protein interaction surface. PLoS One (2010) 0.80

Screening for functional expression and overexpression of a family of diiron-containing interfacial membrane proteins using the univector recombination system. Protein Sci (2003) 0.80

HF-EPR, Raman, UV/VIS light spectroscopic, and DFT studies of the ribonucleotide reductase R2 tyrosyl radical from Epstein-Barr virus. PLoS One (2011) 0.80

Nanobody mediated crystallization of an archeal mechanosensitive channel. PLoS One (2013) 0.80

Structural basis of tumor suppressor in lung cancer 1 (TSLC1) binding to differentially expressed in adenocarcinoma of the lung (DAL-1/4.1B). J Biol Chem (2010) 0.80

Colony filtration blotting for screening soluble expression in Escherichia coli. Nat Protoc (2006) 0.80

Structures of the hydrolase domain of human 10-formyltetrahydrofolate dehydrogenase and its complex with a substrate analogue. Acta Crystallogr D Biol Crystallogr (2006) 0.80

Substrate specificity and oligomerization of human GMP synthetase. J Mol Biol (2013) 0.79

GRETA, a new multifermenter system for structural genomics and process optimization. Acta Crystallogr D Biol Crystallogr (2006) 0.79

A protein carboxylate coordinated oxo-centered tri-nuclear iron complex with possible implications for ferritin mineralization. FEBS Lett (2004) 0.79

Structural and functional studies of the human phosphoribosyltransferase domain containing protein 1. FEBS J (2010) 0.79

Cellobiose quinone oxidoreductase from the white rot fungus Phanerochaete chrysosporium is produced by intracellular proteolysis of cellobiose dehydrogenase. Biochim Biophys Acta (2002) 0.79

X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors. ChemMedChem (2013) 0.79

Crystal structures of the mitochondrial deoxyribonucleotidase in complex with two specific inhibitors. Mol Pharmacol (2004) 0.78